Rare diseases, impacting fewer than 200,000 individuals in the US, present daunting access and reimbursement obstacles, with 95% lacking approved therapy. As the median treatment cost exceeds $200,000 annually, concerns about affordability, access, and value persist for over 10,000 identified rare diseases, affecting 30 million Americans.
Join Molly Borchardt, PharmD, Senior Director of the Access Experience Team at Precision Value & Health, as she unveils crucial insights that can help enhance your access strategy.
What you'll learn:
-
Strategies for navigating the complexities of rare disease management
-
Guidance on engaging with payers early to ensure optimal access
-
Tips for demonstrating the holistic value of your rare disease innovation